newsfilter
← Latest News
GlobeNewswire·

Axovant Gene Therapies Announces Investor Conference Presentations for the Remainder of 2019

NEW YORK and BASEL, Switzerland, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies, Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced that...